These observations, along with those from our in vitro and mouse xenograft cell models, underscore the importance of tumor-produced SPARC over that produced by stromal cells in conferring a metastatic phenotype to prostate cancer tumor cells. The gene discussed is SPARC; the disease is prostate carcinoma.